{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:09:24Z","timestamp":1782140964909,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6-2018-0090"],"award-info":[{"award-number":["6-2018-0090"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.cllc.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:04:33Z","timestamp":1543449873000},"page":"e177-e185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["High Receipt of Statins Reduces the Risk of Lung Cancer in Current Smokers With Hypercholesterolemia: The National Health Insurance Service\u2013Health Screening Cohort"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9021-3856","authenticated-orcid":false,"given":"Yu-Jin","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Young","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1784-6494","authenticated-orcid":false,"given":"Jae-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joungyoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8048-6247","authenticated-orcid":false,"given":"Hee-Taik","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2018.11.009_bib1","series-title":"National Center for Health Statistics. Health, United States, 2016: With Chartbook on Long-Term Trends in Health. Report 2017-1232","year":"2017"},{"key":"10.1016\/j.cllc.2018.11.009_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4143\/crt.2018.143","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015","volume":"50","author":"Jung","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.cllc.2018.11.009_bib3","doi-asserted-by":"crossref","first-page":"14300","DOI":"10.1038\/s41598-017-14513-7","article-title":"Incidence and mortality of lung cancer: global trends and association with socioeconomic status","volume":"7","author":"Wong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cllc.2018.11.009_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1183\/13993003.00359-2016","article-title":"Risk factors for lung cancer worldwide","volume":"48","author":"Malhotra","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cllc.2018.11.009_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ijc.23033","article-title":"Tobacco smoking and cancer: a meta-analysis","volume":"122","author":"Gandini","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2018.11.009_bib7","first-page":"1055","article-title":"Potential antitumor effects of statins","volume":"23","author":"Jakobisiak","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cllc.2018.11.009_bib8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2018.11.009_bib9","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/bjc.2014.431","article-title":"In\u00a0vitro and in\u00a0vivo anticancer effects of mevalonate pathway modulation on human cancer cells","volume":"111","author":"Jiang","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2018.11.009_bib10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.onc.1209117","article-title":"Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling","volume":"25","author":"Khanzada","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.cllc.2018.11.009_bib11","doi-asserted-by":"crossref","first-page":"e77950","DOI":"10.1371\/journal.pone.0077950","article-title":"Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2018.11.009_bib12","doi-asserted-by":"crossref","first-page":"e57349","DOI":"10.1371\/journal.pone.0057349","article-title":"Statins and the risk of lung cancer: a meta-analysis","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2018.11.009_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.295.1.74","article-title":"Statins and cancer risk: a meta-analysis","volume":"295","author":"Dale","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2018.11.009_bib14","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1200\/JCO.2016.69.7391","article-title":"Multicenter, phase III, randomized, double-blind, placebo-controlled trial of pravastatin added to first-line standard chemotherapy in small-cell lung cancer (LUNGSTAR)","volume":"35","author":"Seckl","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2018.11.009_bib15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1378\/chest.06-0931","article-title":"Statins reduce the risk of lung cancer in humans: a large case\u2013control study of US veterans","volume":"131","author":"Khurana","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2018.11.009_bib16","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2018.11.009_bib17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1158\/1055-9965.EPI-15-0052","article-title":"Statin use and survival from lung cancer: a population-based cohort study","volume":"24","author":"Cardwell","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cllc.2018.11.009_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.106.650176","article-title":"Statins and the risk of lung, breast, and colorectal cancer in the elderly","volume":"115","author":"Setoguchi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cllc.2018.11.009_bib19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.20758","article-title":"Cancer risk among statin users: a population-based cohort study","volume":"114","author":"Friis","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2018.11.009_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12913-017-2073-y","article-title":"Measuring medication adherence in patients with incident hypertension: a retrospective cohort study","volume":"17","author":"Tang","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cllc.2018.11.009_bib21","doi-asserted-by":"crossref","first-page":"e016640","DOI":"10.1136\/bmjopen-2017-016640","article-title":"Cohort profile: the National Health Insurance Service\u2013National Health Screening Cohort (NHIS-HEALS) in Korea","volume":"7","author":"Seong","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.cllc.2018.11.009_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/expphysiol.2006.035147","article-title":"Human cholesterol metabolism and therapeutic molecules","volume":"93","author":"Charlton-Menys","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1016\/j.cllc.2018.11.009_bib23","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.cllc.2018.11.009_bib24","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1200\/JCO.2010.31.5200","article-title":"Total cholesterol and cancer risk in a large prospective study in Korea","volume":"29","author":"Kitahara","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2018.11.009_bib25","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cllc.2018.11.009_bib28","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2018.11.009_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(04)16936-5","article-title":"Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)","volume":"364","author":"Strandberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2018.11.009_bib30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa065994","article-title":"Long-term follow-up of the West of Scotland Coronary Prevention Study","volume":"357","author":"Ford","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2018.11.009_bib31","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/archinte.160.15.2363","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case\u2013control study","volume":"160","author":"Blais","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cllc.2018.11.009_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jnci\/djm286","article-title":"The association between statins and cancer incidence in a veterans population","volume":"100","author":"Farwell","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2018.11.009_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3835(96)04465-5","article-title":"Inhibition of lung tumor cell growth in\u00a0vitro and mouse lung tumor formation by lovastatin","volume":"109","author":"Hawk","year":"1996","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cllc.2018.11.009_bib34","first-page":"10","article-title":"The statins as anticancer agents","volume":"9","author":"Chan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2018.11.009_bib35","first-page":"1401","article-title":"HMG-CoA reductase inhibitors (statins) as anticancer drugs (review)","volume":"27","author":"Fritz","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cllc.2018.11.009_bib36","first-page":"2223","article-title":"Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells","volume":"5","author":"Agarwal","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2018.11.009_bib37","first-page":"3602","article-title":"Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin","volume":"51","author":"Keyomarsi","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2018.11.009_bib38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1513\/pats.200809-100TH","article-title":"Smoking and lung cancer: the role of inflammation","volume":"5","author":"Walser","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.cllc.2018.11.009_bib39","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/cncr.25790","article-title":"A\u00a0phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive-disease small cell lung cancer","volume":"117","author":"Han","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2018.11.009_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2018.11.009_bib41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1183\/09031936.00042512","article-title":"Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy","volume":"42","author":"Davis","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cllc.2018.11.009_bib42","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ebiom.2015.09.031","article-title":"Associated links among smoking, chronic obstructive pulmonary disease, and small cell lung cancer: a pooled analysis in the International Lung Cancer Consortium","volume":"2","author":"Huang","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cllc.2018.11.009_bib43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MCP.0000000000000451","article-title":"Chronic obstructive pulmonary disease and lung cancer: inter-relationships","volume":"24","author":"Biswas","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.cllc.2018.11.009_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2015.08.017","article-title":"The relationship between COPD and lung cancer","volume":"90","author":"Durham","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2018.11.009_bib45","doi-asserted-by":"crossref","first-page":"16461","DOI":"10.1038\/srep16461","article-title":"The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research","volume":"5","author":"Cao","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cllc.2018.11.009_bib46","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/ijc.27339","article-title":"Cigarette smoking and lung cancer\u2014relative risk estimates for the major histological types from a pooled analysis of case\u2013control studies","volume":"131","author":"Pesch","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2018.11.009_bib47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4143\/crt.2016.178","article-title":"Lung cancer epidemiology in Korea","volume":"49","author":"Shin","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.cllc.2018.11.009_bib48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1200\/JCO.2006.07.2983","article-title":"Lung cancer incidence in never smokers","volume":"25","author":"Wakelee","year":"2007","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573041830305X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573041830305X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:09:12Z","timestamp":1761505752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152573041830305X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S152573041830305X"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2018.11.009","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Receipt of Statins Reduces the Risk of Lung Cancer in Current Smokers With Hypercholesterolemia: The National Health Insurance Service\u2013Health Screening Cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}